The pre-clinical findings, just published in Cell Chemical Biology, may lay the foundation for improving therapies for treatment-resistant, aggressive prostate cancer.

Amid the incredible diversity of living things on our planet, there is a common theme. Organisms need to acquire new genes, or change the functions of existing genes, in order to adapt and survive.

The taurine-modified photosensitizer created by the OIST research team is a promising new avenue of exploration for enhancing photodynamic therapy for brain cancer.

Children with tuberculosis meningitis have a biological fingerprint that can be used to assess the severity of the condition, help decide the best course of treatment, and provide clues for novel treatments.

Rutgers researchers have invented a technology that could lead to wearable biosensors which could analyze sweat or blood for biomarkers.

PromarkerD blood test predicted 86% of disease-free patients who went on to develop chronic kidney disease within four years.